These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25825556)

  • 1. Response of first-line antibiotic therapy in patients with febrile neutropenia during treatment of hematological disorders.
    Taj M; Qureshi RN; Farzana T; Shamsi TS; Ahmed SS
    Indian J Hematol Blood Transfus; 2015 Jun; 31(2):180-5. PubMed ID: 25825556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of clinical profile and bacterial spectrum and sensitivity patterns of pathogens in febrile neutropenic patients in hematological malignancies: A retrospective analysis from a single center.
    Karanwal AB; Parikh BJ; Goswami P; Panchal HP; Parekh BB; Patel KB
    Indian J Med Paediatr Oncol; 2013 Apr; 34(2):85-8. PubMed ID: 24049293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bloodstream infections in febrile neutropenic patients at a tertiary cancer institute in South India: A timeline of clinical and microbial trends through the years.
    Babu KG; Lokanatha D; Lakshmaiah KC; Suresh Babu MC; Jacob LA; Bhat GR; Vardhana H; Sinha M; Vijaykumar BR; Sumati BG; Jayshree RS
    Indian J Med Paediatr Oncol; 2016; 37(3):174-82. PubMed ID: 27688611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemotherapy-induced febrile neutropenia: About 186 episodes. Clinical, microbiological and therapeutic characteristics].
    Masmoudi S; Khanfir A; Maalej-Mezghan S; Hammami A; Frikha M
    Tunis Med; 2015 Apr; 93(4):217-22. PubMed ID: 26375737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Febrile neutropenia in paediatric peripheral blood stem cell transplantation, in -vitro sensitivity data and clinical response to empirical antibiotic therapy.
    Ansari SH; Nasim S; Ahmed A; Irfan M; Ishaque A; Farzana T; Panjwani VK; Taj M; Shamsi TS
    J Coll Physicians Surg Pak; 2006 Nov; 16(11):704-8. PubMed ID: 17052420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Febrile Neutropenia in Hematological Malignancies: Clinical and Microbiological Profile and Outcome in High Risk Patients.
    Lakshmaiah KC; Malabagi AS; Govindbabu ; Shetty R; Sinha M; Jayashree RS
    J Lab Physicians; 2015; 7(2):116-20. PubMed ID: 26417163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Microbiological Profile of Pathogens in Febrile Neutropenia in Hematological Malignancies: A Single Center Prospective Analysis.
    Taj M; Farzana T; Shah T; Maqsood S; Ahmed SS; Shamsi TS
    J Oncol; 2015; 2015():596504. PubMed ID: 26290665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized prospective study of ceftazidime and ciprofloxacin with or without teicoplanin as an empiric antibiotic regimen for febrile neutropenic patients.
    Lim SH; Smith MP; Goldstone AH; Machin SJ
    Br J Haematol; 1990 Dec; 76 Suppl 2():41-4. PubMed ID: 2149051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-thinking treatment strategies for febrile neutropenia in paediatric oncology population: the perspective from a developing country.
    James V; Prakash A; Mehta K; Durugappa T
    Infect Agent Cancer; 2021 Jun; 16(1):44. PubMed ID: 34147094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors predicting outcome in high risk febrile neutropenia in patients receiving intensive chemotherapy for acute sleukemia: A prospective, observational study from South India.
    Rajendranath R; Balasubramaniyum VK; Vijayakumar V; Ganesan P; Tenali GS
    Indian J Cancer; 2014; 51(4):481-6. PubMed ID: 26842171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy.
    Chen CY; Tang JL; Hsueh PR; Yao M; Huang SY; Chen YC; Chen YC; Shen MC; Wang CH; Tsai W; Chang SC; Tien HF; Luh KT
    J Formos Med Assoc; 2004 Jul; 103(7):526-32. PubMed ID: 15318274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microorganisms isolated from cultures and infection focus and antibiotic treatments in febrile neutropenic children from Şanlıurfa, Turkey.
    Özdemir ZC; Koç A; Ayçiçek A
    Turk J Pediatr; 2016; 58(1):47-53. PubMed ID: 27922236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bloodstream infections in febrile neutropenic patients: bacterial spectrum and antimicrobial susceptibility pattern.
    Butt T; Afzal RK; Ahmad RN; Salman M; Mahmood A; Anwar M
    J Ayub Med Coll Abbottabad; 2004; 16(1):18-22. PubMed ID: 15125174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Etiology of febrile neutropenia episodes among cancer patients from Hospital Clinico Universidad Catolica, Santiago-Chile].
    Rabagliati B R; Fuentes L G; Orellana U E; Oporto C J; Domínguez M I; Benítez G R; Aedo C I; Ramos G G; Garrido S M; García C P
    Rev Chilena Infectol; 2009 Apr; 26(2):106-13. PubMed ID: 19621141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiological spectrum and susceptibility patterns of pathogens causing bacteraemia in paediatric febrile neutropenic oncology patients: comparison between two consecutive time periods with use of different antibiotic treatment protocols.
    Greenberg D; Moser A; Yagupsky P; Peled N; Hofman Y; Kapelushnik J; Leibovitz E
    Int J Antimicrob Agents; 2005 Jun; 25(6):469-73. PubMed ID: 15890499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftazidime and amikacin as empiric antibiotic therapy of febrile granulocytopenic patients with hematological malignancies. Report of 171 consecutive episodes.
    Todeschini G; Veneri D; Carlini S; Pizzolo G; Ambrosetti A; Bonesi R; Cassibba V; Vinante F; Meneghini V; Perona G
    Hematol Oncol; 1991; 9(3):137-46. PubMed ID: 1937406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of Antimicrobial Sensitivity in Microbiologically Documented Infections in Neutropenic Patients with Haematological Malignancies: A single Center Study.
    Jamal A; Fatima N; Shaikh S; Kaleem B; Rizvi QA; Zaidi U; Borhany M; Shamsi T
    Indian J Microbiol; 2019 Jun; 59(2):188-192. PubMed ID: 31031433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey.
    Agaoglu L; Devecioglu O; Anak S; Karakas Z; Yalman N; Biner B; Eryilmaz E; Goksan B; Unuvar A; Agirbasli H; Can M; Bilgen H; Gedikoglu G
    J Chemother; 2001 Jun; 13(3):281-7. PubMed ID: 11450887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised comparison of ceftazidime and imipenem as initial monotherapy for febrile episodes in neutropenic cancer patients.
    Aparicio J; Oltra A; Llorca C; Montalar J; Herranz C; Gómez-Codina J; Pastor M; Munárriz B
    Eur J Cancer; 1996 Sep; 32A(10):1739-43. PubMed ID: 8983283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients.
    Behre G; Link H; Maschmeyer G; Meyer P; Paaz U; Wilhelm M; Hiddemann W
    Ann Hematol; 1998 Feb; 76(2):73-80. PubMed ID: 9540761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.